Cybersecurity

Cost-cutting, growth could lift Symantec shares 25 percent: Barron’s

Cost-cutting, growth could lift Symantec shares 25 percent: Barron’s

Published 28/08/2016

The Symantec booth is seen during the 2016 Black Hat cyber-security conference in Las Vegas, Nevada, U.S. August 3, 2016. REUTERS/David Becker

Symantec Corp shares could gain 25 percent or more following steps to cut costs and a recent acquisition that could propel the company's business in the hot cybersecurity market, a Barron's report said on Sunday.

[more…]

Israeli tech group Shellanoo plans Tel Aviv IPO

Israeli tech group Shellanoo plans Tel Aviv IPO

Published 28/08/2016

Israeli technology company Shellanoo is planning to raise at least 100 million shekels ($26.5 million) in an initial public offering (IPO) on the Tel Aviv Stock Exchange in late September or October, it said on Sunday.

[more…]

Iran detects malware in petrochemical plants, says not linked to recent fires

Iran detects malware in petrochemical plants, says not linked to recent fires

Published 27/08/2016

Iran has detected and removed malicious software from two of its petrochemical complexes, a senior military official said on Saturday, after announcing last week it was investigating whether recent petrochemical fires were caused by cyber attacks.

[more…]

St. Jude says report by short sellers ‘false and misleading’

St. Jude says report by short sellers ‘false and misleading’

Published 26/08/2016

The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid

Medical device manufacturer St. Jude Medical Inc (STJ.N) said on Friday a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading."

[more…]

Whiplashed investors stay skittish about St. Jude

Whiplashed investors stay skittish about St. Jude

Published 26/08/2016

One day after a short seller claimed that St. Jude Medical Inc's (STJ.N) heart implants are vulnerable to deadly cyber attacks, investors appear most concerned about whether the accusation will derail St. Jude's $24 billion planned deal for Abbott Labs (ABT.N) to buy it.St. Jude's stock at one point fell around 3 percent on Friday, though it ended the day slightly up, following a drop of around 5 percent on Thursday after Muddy Waters Capital leveled the accusation against St. Jude. The stock continues to trade well below its price on Wednesday of around $82 per share.

[more…]